Showing 1,041 - 1,060 results of 226,405 for search '(( a ((mean decrease) OR (a decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 1.73s Refine Results
  1. 1041
  2. 1042
  3. 1043
  4. 1044
  5. 1045

    Decreased FC in HF over control subjects. by Bumhee Park (460428)

    Published 2016
    “…Bigger nodal sphere size represents a larger number of significant edges. Bold yellow labels indicate sites with at least 3 functional connections. …”
  6. 1046
  7. 1047
  8. 1048
  9. 1049

    Effect of Acute Phenylalanine and Tyrosine Depletion (APTD) on Non-Transformed (A) and Log Transformed (B) Progressive Ratio (PR) Exercise Breakpoint Scores in Individuals Recovere... by Caitlin B. O’Hara (847826)

    Published 2016
    “…<p>Relative to the balanced condition (BAL), APTD resulted in a significant decrease in PR breakpoint scores among HC only (HC BAL: 1.18 ± 0.76; HC APTD: 0.39 ± 0.68). …”
  10. 1050
  11. 1051

    CNP decrease the number of cristae in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…Transmission electron microscopy for cristae quantification was performed as described in the Methods section. CNP significantly decreased the number of cristae in the mitochondrial inner membrane in A375 cells. …”
  12. 1052
  13. 1053

    cAMP production is decreased in FX fly. by Daniel J. Kelley (35705)

    Published 2013
    “…(a) RF-based cAMP measures in the fly head (Control n = 10, FX n = 3, FXR+ n = 6; FXR++ n = 6 sets of 20 heads) are comparable between groups in the absence of forskolin [F(3,21) = 1.96; p = 0.15], but not its presence [F(3,21) = 6.23;p = 0.003], since RF intensity in FX flies is larger than the others [t(21) = −4.10;p = 0.000]. …”
  14. 1054
  15. 1055
  16. 1056

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  17. 1057
  18. 1058
  19. 1059

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”
  20. 1060